Social Media Buzz 5/3/12

Oxford Nanopore Oxford Nanopore to Pocket £31.4M to Advance Single-Molecule Detection Technology

Delcath is actively enrolling patients in a Phase III clinical trial testing its proprietary drug delivery system, known as Percutaneous Hepatic Perfusion

Biodel Biodel's ultra-rapid-acting insulin programmes receives European patent

Corornado Biosciences Corornado Biosciences today announced that an oral presentation on TSO (Trichuris suis ova or CNDO-201) will be presented at the 8th International Congress on Autoimmunity to be held May 9-13, 2012 The presentation will provide an evaluation of Safety and Tolerability of Trichuris suis ova in Patients with Crohn's Disease